U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H26N2O
Molecular Weight 274.4011
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE

SMILES

COC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1

InChI

InChIKey=DNBPMBJFRRVTSJ-UHFFFAOYSA-N
InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3

HIDE SMILES / InChI

Molecular Formula C17H26N2O
Molecular Weight 274.4011
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
The hallucinogenic world of tryptamines: an updated review.
2015-08
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.
2010-06-24
Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
2009-06
Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.
2009-03-27
Indolealkylamines: biotransformations and potential drug-drug interactions.
2008-06
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats.
2008-05-30
The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
2008-03-10
Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods.
2008-02-15
Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.
2008-02-01
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
2008-02
A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation.
2008-01-15
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
2008-01
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
2007-06
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
2007-04-05
Acute confusional state after designer tryptamine abuse.
2007-04
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
2007-03-22
Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan.
2006-12-20
A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
2006-11-10
Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan.
2006-09-26
[Analysis of the chemical drugs among structural isomer].
2006-09
Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
2006-04-28
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
2006-04
Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
2006-02
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
2006-01
False positives and false negatives with a cocaine-specific field test and modification of test protocol to reduce false decision.
2005-12-20
Foxy methoxy: a new drug of abuse.
2005-12
Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry.
2005-08-25
A foxy intoxication.
2005-02-10
Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
2004-11
Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
2004-09-29
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
2004-09
[Latest cases of acute poisoning in clinical practice--5MeO-DIPT and GHB precursor].
2004-07
Foxy, a designer tryptamine hallucinogen.
2003-08-12
Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
2003-04-04
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:08:42 GMT 2025
Edited
by admin
on Mon Mar 31 19:08:42 GMT 2025
Record UNII
12D06G8W8E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE
MI  
Systematic Name English
5-MEO-DIPT
Preferred Name English
3-(2-(DIISOPROPYLAMINO)ETHYL)-5-METHOXYINDOLE
Systematic Name English
METHOXY FOXY
Common Name English
5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE [MI]
Common Name English
FOXY
Common Name English
5-METHOXY-N,N-BIS(1-METHYLETHYL)-1H-INDOLE-3-ETHANAMINE
Systematic Name English
Classification Tree Code System Code
DEA NO. 7439
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
WIKIPEDIA TiHKAL
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
WIKIPEDIA Designer-drugs-5-MeO-DiPT
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
Code System Code Type Description
MERCK INDEX
m7332
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID00193209
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
FDA UNII
12D06G8W8E
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
DRUG BANK
DB01441
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
PUBCHEM
151182
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
CAS
4021-34-5
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
SMS_ID
300000042749
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
CHEBI
48282
Created by admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
The strongest receptor binding affinity for 5-MeO-DiPT is at the 5-HT1A receptor.
TARGET -> AGONIST
METABOLIC ENZYME -> SUBSTRATE
MAJOR
Related Record Type Details
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
MAJOR
URINE
METABOLITE -> PARENT
MAJOR
URINE
Related Record Type Details
ACTIVE MOIETY
A psychedelic tryptamine and the methoxy derivative of diisopropyltryptamine (DiPT).